Prudential Financial’s Design Therapeutics DSGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $195K | Buy |
57,925
+1,520
| +3% | +$5.12K | ﹤0.01% | 2217 |
|
2025
Q1 | $218K | Buy |
56,405
+90
| +0.2% | +$347 | ﹤0.01% | 2058 |
|
2024
Q4 | $347K | Sell |
56,315
-2,800
| -5% | -$17.3K | ﹤0.01% | 1951 |
|
2024
Q3 | $318K | Sell |
59,115
-4,100
| -6% | -$22.1K | ﹤0.01% | 2380 |
|
2024
Q2 | $212K | Buy |
63,215
+16,400
| +35% | +$54.9K | ﹤0.01% | 2468 |
|
2024
Q1 | $189K | Buy |
46,815
+28,400
| +154% | +$114K | ﹤0.01% | 2477 |
|
2023
Q4 | $48.8K | Hold |
18,415
| – | – | ﹤0.01% | 2552 |
|
2023
Q3 | $43.5K | Sell |
18,415
-7,800
| -30% | -$18.4K | ﹤0.01% | 2514 |
|
2023
Q2 | $165K | Buy |
+26,215
| New | +$165K | ﹤0.01% | 2452 |
|